Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.8.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Convertible series A preferred shares
Common Shares
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Balance (in shares) at Dec. 31, 2015   0 39,833,000      
Balance at Dec. 31, 2015 $ 31,128 $ 0 $ 40 $ 112,227 $ (1,273) $ (79,866)
Increase (Decrease) in Stockholders' Equity            
Net loss (22,799)         (22,799)
Foreign currency translation adjustment (229)       (229)  
Unrealized losses on investments 0          
Stock based compensation expense 1,905     1,905    
Issuance of common and preferred stock, net of offering costs (in shares)   5,000 3,226,000      
Issuance of common and preferred stock, net of offering costs 15,221   $ 3 15,218    
Issuance of common stock resulting from exercise of stock options (in shares)     0      
Issuance of common stock resulting from exercise of warrants (in shares)     0      
Balance (in shares) at Dec. 31, 2016   5,000 43,059,000      
Balance at Dec. 31, 2016 25,227 $ 0 $ 43 129,350 (1,501) (102,665)
Increase (Decrease) in Stockholders' Equity            
Net loss (17,647)         (17,647)
Foreign currency translation adjustment (2,374)       (2,374)  
Unrealized losses on investments (820)       (820)  
Stock based compensation expense 3,046     3,046    
Issuance of common stock resulting from exercise of stock options (in shares)     453,209      
Issuance of common stock resulting from exercise of stock options 781     781    
Issuance of common stock resulting from exercise of warrants (in shares)     1,505,026      
Issuance of common stock resulting from exercise of warrants 3,309   $ 2 3,307    
Balance (in shares) at Dec. 31, 2017   5,000 45,017,000      
Balance at Dec. 31, 2017 $ 11,522 $ 0 $ 45 $ 136,484 $ (4,695) $ (120,312)